Skip to main content
×
Home
    • Aa
    • Aa

Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study

  • Sarah Egert (a1), Anja Bosy-Westphal (a1), Jasmin Seiberl (a1), Claudia Kürbitz (a1), Uta Settler (a1), Sandra Plachta-Danielzik (a1), Anika E. Wagner (a2), Jan Frank (a2), Jürgen Schrezenmeir (a3), Gerald Rimbach (a2), Siegfried Wolffram (a4) and Manfred J. Müller (a1)...
Abstract

Regular consumption of flavonoids may reduce the risk for CVD. However, the effects of individual flavonoids, for example, quercetin, remain unclear. The present study was undertaken to examine the effects of quercetin supplementation on blood pressure, lipid metabolism, markers of oxidative stress, inflammation, and body composition in an at-risk population of ninety-three overweight or obese subjects aged 25–65 years with metabolic syndrome traits. Subjects were randomised to receive 150 mg quercetin/d in a double-blinded, placebo-controlled cross-over trial with 6-week treatment periods separated by a 5-week washout period. Mean fasting plasma quercetin concentrations increased from 71 to 269 nmol/l (P < 0·001) during quercetin treatment. In contrast to placebo, quercetin decreased systolic blood pressure (SBP) by 2·6 mmHg (P < 0·01) in the entire study group, by 2·9 mmHg (P < 0·01) in the subgroup of hypertensive subjects and by 3·7 mmHg (P < 0·001) in the subgroup of younger adults aged 25–50 years. Quercetin decreased serum HDL-cholesterol concentrations (P < 0·001), while total cholesterol, TAG and the LDL:HDL-cholesterol and TAG:HDL-cholesterol ratios were unaltered. Quercetin significantly decreased plasma concentrations of atherogenic oxidised LDL, but did not affect TNF-α and C-reactive protein when compared with placebo. Quercetin supplementation had no effects on nutritional status. Blood parameters of liver and kidney function, haematology and serum electrolytes did not reveal any adverse effects of quercetin. In conclusion, quercetin reduced SBP and plasma oxidised LDL concentrations in overweight subjects with a high-CVD risk phenotype. Our findings provide further evidence that quercetin may provide protection against CVD.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Professor Manfred James Müller, fax +49 431 8805679, email mmueller@nutrfoodsc.uni-kiel.de
References
Hide All
1Erdman JW Jr, Balentine D, Arab L, et al. (2007) Flavonoids and heart health: Proceedings of the ILSI North America Flavonoids Workshop, May 31–June 1, 2005, Washington, DC. J Nutr 137, Suppl., 718S737S.
2Knekt P, Kumpulainen J, Jarvinen R, et al. (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76, 560568.
3Linseisen J, Radtke J & Wolfram G (1997) Flavonoidzufuhr Erwachsener in einem Bayrischen Teilkollektiv der Nationalen Verzehrsstudie (Flavonoid intake of adults in a Bavarian subgroup of the national food consumption survey). Z Ernahrungswiss 36, 403412.
4Böhm H, Boeing H, Hempel J, et al. (1998) Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases (article in German). Z Ernahrungswiss 37, 147163.
5Williamson G & Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81, 243S255S.
6Hooper L, Kroon PA, Rimm EB, et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88, 3850.
7Cassidy A, de Pascual TS & Rimbach G (2003) Molecular mechanisms by which dietary isoflavones potentially prevent atherosclerosis. Expert Rev Mol Med 5, 115.
8Rimbach G, Boesch-Saadatmandi C, Frank J, et al. (2008) Dietary isoflavones in the prevention of cardiovascular disease – a molecular perspective. Food Chem Toxicol 46, 13081319.
9Egert S, Wolffram S, Bosy-Westphal A, et al. (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138, 16151621.
10Danielzik S, Czerwinski-Mast M, Langnase K, et al. (2004) Parental overweight, socioeconomic status and high birth weight are the major determinants of overweight and obesity in 5–7 y-old children: baseline data of the Kiel Obesity Prevention Study (KOPS). Int J Obes Relat Metab Disord 28, 14941502.
11Scales DC & Rubenfeld GD (2005) Estimating sample size in critical care clinical trials. J Crit Care 20, 611.
12Bosy-Westphal A, Danielzik S, Becker C, et al. (2005) Need for optimal body composition data analysis using air-displacement plethysmography in children and adolescents. J Nutr 135, 22572262.
13World Health Organization (2000) Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series no. 894. Geneva: WHO.
14Pickering TG, Hall JE, Appel LJ, et al. (2005) Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45, 142161.
15Cao G, Alessio HM & Cutler RG (1993) Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 14, 303311.
16Bieger J, Cermak R, Blank R, et al. (2008) Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 138, 14171420.
17Kenward MG & Jones B (1987) The analysis of data from 2 × 2 cross-over trials with baseline measurements. Stat Med 6, 911926.
18Chobanian AV, Bakris GL, Black HR, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 25602572.
19Conquer JA, Maiani G, Azzini E, et al. (1998) Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 128, 593597.
20Edwards RL, Lyon T, Litwin SE, et al. (2007) Quercetin reduces blood pressure in hypertensive subjects. J Nutr 137, 24052411.
21Williams B, Lindholm LH & Sever P (2008) Systolic pressure is all that matters. Lancet 371, 22192221.
22Landmesser U, Hornig B & Drexler H (2004) Endothelial function: a critical determinant in atherosclerosis? Circulation 109, II27II33.
23Loke WM, Hodgson JM, Proudfoot JM, et al. (2008) Pure dietary flavonoids quercetin and ( − )-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88, 10181025.
24Perez-Vizcaino F, Duarte J & Andriantsitohaina R (2006) Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic Res 40, 10541065.
25Morris MC, Sacks F & Rosner B (1993) Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88, 523533.
26Lotito SB & Frei B (2006) Dietary flavonoids attenuate tumor necrosis factor α-induced adhesion molecule expression in human aortic endothelial cells. Structure–function relationships and activity after first pass metabolism. J Biol Chem 281, 3710237110.
27Stocker R & Keaney JF (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84, 13811478.
28Holvoet P, Kritchevsky SB, Tracy RP, et al. (2004) The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53, 10681073.
29Holvoet P (2008) Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg 70, 193219.
30Ruel G, Pomerleau S, Couture P, et al. (2005) Changes in plasma antioxidant capacity and oxidized low-density ipoprotein levels in men after short-term cranberry juice consumption. Metabolism 54, 856861.
31Loke WM, Proudfoot JM, McKinley AJ, et al. (2008) Quercetin and its in vivo metabolites inhibit neutrophil-mediated low-density lipoprotein oxidation. J Agric Food Chem 56, 36093615.
32Kawai Y, Nishikawa T, Shiba Y, et al. (2008) Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 283, 94249434.
33Nair MP, Mahajan S, Reynolds JL, et al. (2006) The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor α) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-κB system. Clin Vaccine Immunol 13, 319328.
34Rivera L, Moron R, Sanchez M, et al. (2008) Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 16, 20812087.
35Hotamisligil GS, Arner P, Caro JF, et al. (1995) Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95, 24092415.
36Esposito K, Nappo F, Giugliano F, et al. (2003) Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 78, 11351140.
37Galisteo M, Sanchez M, Vera R, et al. (2005) A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-α in obese Zucker rats. J Nutr 135, 23992404.
38Boots AW, Wilms LC, Swennen EL, et al. (2008) In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 24, 703710.
39Boesch-Saadatmandi C, Wolffram S, Minihane AM, et al. (2008) Effect of apoE genotype and dietary quercetin on blood lipids and TNF-α levels in apoE3 and apoE4 targeted gene replacement mice. Br J Nutr (Epublication ahead of print version 6 November 2008).
40Berube-Parent S, Pelletier C, Dore J, et al. (2005) Effects of encapsulated green tea and guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men. Br J Nutr 94, 432436.
41Dulloo AG, Duret C, Rohrer D, et al. (1999) Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70, 10401045.
42Venables MC, Hulston CJ, Cox HR, et al. (2008) Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr 87, 778784.
43Nagao T, Komine Y, Soga S, et al. (2005) Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr 81, 122129.
44Igarashi K & Ohmuma M (1995) Effects of isorhamnetin, rhamnetin, and quercetin on the concentrations of cholesterol and lipoperoxide in the serum and liver and on the blood and liver antioxidative enzyme activities of rats. Biosci Biotechnol Biochem 59, 595601.
45Yugarani T, Tan BK, Teh M, et al. (1992) Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids 27, 181186.
46Castilla P, Echarri R, Davalos A, et al. (2006) Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 84, 252262.
47Zern TL, Wood RJ, Greene C, et al. (2005) Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 135, 19111917.
48Theriault A, Wang Q, Van Iderstine SC, et al. (2000) Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid. J Lipid Res 41, 19691979.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 57
Total number of PDF views: 397 *
Loading metrics...

Abstract views

Total abstract views: 1058 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st October 2017. This data will be updated every 24 hours.